25 XP   0   0   10

Evrofarma SA
Buy, Hold or Sell?

Let's analyse Evrofarma together

PenkeI guess you are interested in Evrofarma SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Evrofarma SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Evrofarma SA

I send you an email if I find something interesting about Evrofarma SA.

Quick analysis of Evrofarma (30 sec.)










What can you expect buying and holding a share of Evrofarma? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€1.03
Expected worth in 1 year
€1.44
How sure are you?
88.9%

+ What do you gain per year?

Total Gains per Share
€0.42
Return On Investment
28.3%

For what price can you sell your share?

Current Price per Share
€1.47
Expected price per share
€1.28 - €1.94
How sure are you?
50%

1. Valuation of Evrofarma (5 min.)




Live pricePrice per Share (EOD)

€1.47

2. Growth of Evrofarma (5 min.)




Is Evrofarma growing?

Current yearPrevious yearGrowGrow %
How rich?$14.8m$13.3m$1.5m10.1%

How much money is Evrofarma making?

Current yearPrevious yearGrowGrow %
Making money$1.5m-$377k$1.8m125.0%
Net Profit Margin3.1%-1.0%--

How much money comes from the company's main activities?

3. Financial Health of Evrofarma (5 min.)




4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  

What can you expect buying and holding a share of Evrofarma? (5 min.)

Welcome investor! Evrofarma's management wants to use your money to grow the business. In return you get a share of Evrofarma.

What can you expect buying and holding a share of Evrofarma?

First you should know what it really means to hold a share of Evrofarma. And how you can make/lose money.

Speculation

The Price per Share of Evrofarma is €1.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Evrofarma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Evrofarma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.03. Based on the TTM, the Book Value Change Per Share is €0.10 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Evrofarma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.117.5%0.117.5%-0.03-1.9%0.053.4%0.042.6%
Usd Book Value Change Per Share0.117.5%0.117.5%-0.03-1.8%0.053.5%0.128.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.117.5%0.117.5%-0.03-1.8%0.053.5%0.128.2%
Usd Price Per Share0.76-0.76-0.97-0.93-0.62-
Price to Earnings Ratio6.86-6.86--35.05-18.92-13.20-
Price-to-Total Gains Ratio6.85-6.85--35.96-13.24-11.33-
Price to Book Ratio0.69-0.69-0.99-0.96-0.66-
Price-to-Total Gains Ratio6.85-6.85--35.96-13.24-11.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.561287
Number of shares640
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.110.05
Usd Total Gains Per Share0.110.05
Gains per Quarter (640 shares)70.6932.80
Gains per Year (640 shares)282.77131.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102832730131121
205665560262252
308488390394383
40113111220525514
50141414050656645
60169716880787776
70197919710918907
8022622254010501038
9025452537011811169
10028282820013121300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%7.02.00.077.8%7.02.00.077.8%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.01.00.088.9%8.01.00.088.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.01.00.088.9%8.01.00.088.9%

Fundamentals of Evrofarma

About Evrofarma SA

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Fundamental data was last updated by Penke on 2024-03-30 21:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.

1.1. Profitability of Evrofarma SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Evrofarma earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Evrofarma to the Packaged Foods industry mean.
  • A Net Profit Margin of 3.1% means that €0.03 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Evrofarma SA:

  • The MRQ is 3.1%. The company is making a profit. +1
  • The TTM is 3.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.1%TTM3.1%0.0%
TTM3.1%YOY-1.0%+4.1%
TTM3.1%5Y1.8%+1.4%
5Y1.8%10Y1.4%+0.4%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1%3.0%+0.1%
TTM3.1%2.9%+0.2%
YOY-1.0%3.0%-4.0%
5Y1.8%3.4%-1.6%
10Y1.4%3.6%-2.2%
1.1.2. Return on Assets

Shows how efficient Evrofarma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Evrofarma to the Packaged Foods industry mean.
  • 2.9% Return on Assets means that Evrofarma generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Evrofarma SA:

  • The MRQ is 2.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.9%TTM2.9%0.0%
TTM2.9%YOY-0.8%+3.7%
TTM2.9%5Y1.4%+1.5%
5Y1.4%10Y1.1%+0.3%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9%1.4%+1.5%
TTM2.9%1.4%+1.5%
YOY-0.8%1.4%-2.2%
5Y1.4%1.5%-0.1%
10Y1.1%1.7%-0.6%
1.1.3. Return on Equity

Shows how efficient Evrofarma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Evrofarma to the Packaged Foods industry mean.
  • 10.1% Return on Equity means Evrofarma generated €0.10 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Evrofarma SA:

  • The MRQ is 10.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY-2.8%+12.9%
TTM10.1%5Y5.1%+5.0%
5Y5.1%10Y4.1%+1.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1%3.0%+7.1%
TTM10.1%2.9%+7.2%
YOY-2.8%3.1%-5.9%
5Y5.1%3.0%+2.1%
10Y4.1%3.2%+0.9%

1.2. Operating Efficiency of Evrofarma SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Evrofarma is operating .

  • Measures how much profit Evrofarma makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Evrofarma to the Packaged Foods industry mean.
  • An Operating Margin of 6.0% means the company generated €0.06  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Evrofarma SA:

  • The MRQ is 6.0%. The company is operating less efficient.
  • The TTM is 6.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.0%TTM6.0%0.0%
TTM6.0%YOY0.6%+5.4%
TTM6.0%5Y4.7%+1.4%
5Y4.7%10Y5.4%-0.7%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%5.0%+1.0%
TTM6.0%3.6%+2.4%
YOY0.6%4.9%-4.3%
5Y4.7%5.2%-0.5%
10Y5.4%5.1%+0.3%
1.2.2. Operating Ratio

Measures how efficient Evrofarma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 0.69 means that the operating costs are €0.69 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Evrofarma SA:

  • The MRQ is 0.692. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.692. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.692TTM0.6920.000
TTM0.692YOY0.708-0.016
TTM0.6925Y0.860-0.168
5Y0.86010Y1.210-0.350
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6921.551-0.859
TTM0.6921.515-0.823
YOY0.7081.455-0.747
5Y0.8601.394-0.534
10Y1.2101.257-0.047

1.3. Liquidity of Evrofarma SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Evrofarma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 1.48 means the company has €1.48 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Evrofarma SA:

  • The MRQ is 1.477. The company is just able to pay all its short-term debts.
  • The TTM is 1.477. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.477TTM1.4770.000
TTM1.477YOY1.668-0.191
TTM1.4775Y1.301+0.176
5Y1.30110Y1.120+0.180
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4771.561-0.084
TTM1.4771.607-0.130
YOY1.6681.604+0.064
5Y1.3011.638-0.337
10Y1.1201.630-0.510
1.3.2. Quick Ratio

Measures if Evrofarma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Evrofarma to the Packaged Foods industry mean.
  • A Quick Ratio of 1.04 means the company can pay off €1.04 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Evrofarma SA:

  • The MRQ is 1.038. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.038. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.038TTM1.0380.000
TTM1.038YOY1.366-0.328
TTM1.0385Y1.016+0.022
5Y1.01610Y0.859+0.157
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0380.554+0.484
TTM1.0380.566+0.472
YOY1.3660.612+0.754
5Y1.0160.704+0.312
10Y0.8590.728+0.131

1.4. Solvency of Evrofarma SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Evrofarma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Evrofarma to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.71 means that Evrofarma assets are financed with 71.3% credit (debt) and the remaining percentage (100% - 71.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Evrofarma SA:

  • The MRQ is 0.713. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.713. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.713TTM0.7130.000
TTM0.713YOY0.729-0.016
TTM0.7135Y0.722-0.010
5Y0.72210Y0.747-0.025
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7130.484+0.229
TTM0.7130.488+0.225
YOY0.7290.481+0.248
5Y0.7220.483+0.239
10Y0.7470.492+0.255
1.4.2. Debt to Equity Ratio

Measures if Evrofarma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Evrofarma to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 248.0% means that company has €2.48 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Evrofarma SA:

  • The MRQ is 2.480. The company is just not able to pay all its debts with equity.
  • The TTM is 2.480. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.480TTM2.4800.000
TTM2.480YOY2.691-0.211
TTM2.4805Y2.603-0.123
5Y2.60310Y3.015-0.412
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4800.950+1.530
TTM2.4800.955+1.525
YOY2.6910.939+1.752
5Y2.6030.995+1.608
10Y3.0151.074+1.941

2. Market Valuation of Evrofarma SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Evrofarma generates.

  • Above 15 is considered overpriced but always compare Evrofarma to the Packaged Foods industry mean.
  • A PE ratio of 6.86 means the investor is paying €6.86 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Evrofarma SA:

  • The EOD is 14.165. Based on the earnings, the company is underpriced. +1
  • The MRQ is 6.861. Based on the earnings, the company is cheap. +2
  • The TTM is 6.861. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.165MRQ6.861+7.304
MRQ6.861TTM6.8610.000
TTM6.861YOY-35.050+41.910
TTM6.8615Y18.919-12.059
5Y18.91910Y13.196+5.724
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD14.16513.623+0.542
MRQ6.86112.534-5.673
TTM6.86113.933-7.072
YOY-35.05012.854-47.904
5Y18.91916.330+2.589
10Y13.19619.210-6.014
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Evrofarma SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.087-3.087
TTM-1.634-1.634
YOY-0.370-0.370
5Y-1.347-1.347
10Y-1.376-1.376
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Evrofarma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 0.69 means the investor is paying €0.69 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Evrofarma SA:

  • The EOD is 1.433. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.694. Based on the equity, the company is cheap. +2
  • The TTM is 0.694. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.433MRQ0.694+0.739
MRQ0.694TTM0.6940.000
TTM0.694YOY0.987-0.293
TTM0.6945Y0.957-0.263
5Y0.95710Y0.659+0.298
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD1.4331.413+0.020
MRQ0.6941.461-0.767
TTM0.6941.443-0.749
YOY0.9871.762-0.775
5Y0.9571.856-0.899
10Y0.6592.419-1.760
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Evrofarma SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1040.1040%-0.025+124%0.048+116%0.114-9%
Book Value Per Share--1.0261.0260%0.922+11%0.923+11%0.838+22%
Current Ratio--1.4771.4770%1.668-11%1.301+14%1.120+32%
Debt To Asset Ratio--0.7130.7130%0.729-2%0.722-1%0.747-5%
Debt To Equity Ratio--2.4802.4800%2.691-8%2.603-5%3.015-18%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1040.1040%-0.026+125%0.048+118%0.036+187%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap20099604.000+52%9735318.4009735318.4000%12442612.000-22%11994131.040-19%7971475.600+22%
Net Profit Margin--0.0310.0310%-0.010+131%0.018+77%0.014+122%
Operating Margin--0.0600.0600%0.006+854%0.047+29%0.054+12%
Operating Ratio--0.6920.6920%0.708-2%0.860-20%1.210-43%
Pb Ratio1.433+52%0.6940.6940%0.987-30%0.957-28%0.659+5%
Pe Ratio14.165+52%6.8616.8610%-35.050+611%18.919-64%13.196-48%
Price Per Share1.470+52%0.7120.7120%0.910-22%0.877-19%0.583+22%
Price To Free Cash Flow Ratio----0%-0%-0%-0%
Price To Total Gains Ratio14.135+52%6.8466.8460%-35.961+625%13.245-48%11.328-40%
Quick Ratio--1.0381.0380%1.366-24%1.016+2%0.859+21%
Return On Assets--0.0290.0290%-0.008+126%0.014+106%0.011+167%
Return On Equity--0.1010.1010%-0.028+128%0.051+99%0.041+148%
Total Gains Per Share--0.1040.1040%-0.025+124%0.048+116%0.114-9%
Usd Book Value--14898076.70014898076.7000%13387770.500+11%13405613.780+11%12166591.522+22%
Usd Book Value Change Per Share--0.1100.1100%-0.027+124%0.051+116%0.121-9%
Usd Book Value Per Share--1.0901.0900%0.979+11%0.980+11%0.890+22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1100.1100%-0.028+125%0.051+118%0.038+187%
Usd Free Cash Flow----0%-0%-0%-0%
Usd Market Cap21347789.408+52%10339881.67310339881.6730%13215298.205-22%12738966.578-19%8466504.235+22%
Usd Price Per Share1.561+52%0.7560.7560%0.967-22%0.932-19%0.619+22%
Usd Profit--1507119.9001507119.9000%-377045.500+125%696737.600+116%528099.722+185%
Usd Revenue--48199160.10048199160.1000%38978007.900+24%38661289.680+25%34986636.100+38%
Usd Total Gains Per Share--0.1100.1100%-0.027+124%0.051+116%0.121-9%
 EOD+4 -3MRQTTM+0 -0YOY+21 -65Y+23 -410Y+20 -7

3.2. Fundamental Score

Let's check the fundamental score of Evrofarma SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.165
Price to Book Ratio (EOD)Between0-11.433
Net Profit Margin (MRQ)Greater than00.031
Operating Margin (MRQ)Greater than00.060
Quick Ratio (MRQ)Greater than11.038
Current Ratio (MRQ)Greater than11.477
Debt to Asset Ratio (MRQ)Less than10.713
Debt to Equity Ratio (MRQ)Less than12.480
Return on Equity (MRQ)Greater than0.150.101
Return on Assets (MRQ)Greater than0.050.029
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Evrofarma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.625
Ma 20Greater thanMa 501.682
Ma 50Greater thanMa 1001.598
Ma 100Greater thanMa 2001.406
OpenGreater thanClose1.490
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Retained Earnings  -1,312216-1,0961,089-7-375-3821,342960



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets48,814
Total Liabilities34,787
Total Stockholder Equity14,027
 As reported
Total Liabilities 34,787
Total Stockholder Equity+ 14,027
Total Assets = 48,814

Assets

Total Assets48,814
Total Current Assets18,711
Long-term Assets-
Total Current Assets
Net Receivables 11,716
Inventory 5,558
Other Current Assets 310
Total Current Assets  (as reported)18,711
Total Current Assets  (calculated)17,584
+/- 1,127
Long-term Assets
Property Plant Equipment 24,149
Intangible Assets 59
Long-term Assets  (as reported)0
Long-term Assets  (calculated)24,208
+/- 24,208

Liabilities & Shareholders' Equity

Total Current Liabilities12,670
Long-term Liabilities-
Total Stockholder Equity14,027
Total Current Liabilities
Short-term Debt 2,436
Accounts payable 4,450
Other Current Liabilities 2,581
Total Current Liabilities  (as reported)12,670
Total Current Liabilities  (calculated)9,467
+/- 3,203
Long-term Liabilities
Long term Debt Total 16,194
Capital Lease Obligations Min Short Term Debt-2,436
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)13,758
+/- 13,758
Total Stockholder Equity
Common Stock12,032
Retained Earnings 960
Capital Surplus 935
Other Stockholders Equity 100
Total Stockholder Equity (as reported)14,027
Total Stockholder Equity (calculated)14,027
+/-0
Other
Cash And Equivalents1,437
Cash and Short Term Investments 1,437
Common Stock Shares Outstanding 13,673
Liabilities and Stockholders Equity 48,814
Net Tangible Assets 13,968



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
47,269
44,346
43,753
45,095
44,231
41,200
46,375
46,520
48,814
48,81446,52046,37541,20044,23145,09543,75344,34647,269
   > Total Current Assets 
14,079
13,568
14,655
16,626
15,892
13,188
18,833
17,008
18,711
18,71117,00818,83313,18815,89216,62614,65513,56814,079
       Cash And Cash Equivalents 
106
454
152
819
554
106
3,108
0
0
003,108106554819152454106
       Net Receivables 
9,858
10,088
10,726
12,274
12,013
10,002
12,153
13,685
11,716
11,71613,68512,15310,00212,01312,27410,72610,0889,858
       Inventory 
4,115
3,026
3,777
3,533
3,325
3,080
3,572
3,074
5,558
5,5583,0743,5723,0803,3253,5333,7773,0264,115
   > Long-term Assets 000000000
       Property Plant Equipment 
27,684
25,987
27,782
23,958
23,559
22,986
22,455
24,410
24,149
24,14924,41022,45522,98623,55923,95827,78225,98727,684
       Long Term Investments 
7
118
91
68
25
0
0
0
0
00002568911187
       Intangible Assets 
357
321
274
240
202
167
129
98
59
5998129167202240274321357
> Total Liabilities 
38,003
34,553
33,552
34,367
32,576
29,329
33,424
33,915
34,787
34,78733,91533,42429,32932,57634,36733,55234,55338,003
   > Total Current Liabilities 
15,016
13,130
15,073
26,114
15,781
22,250
10,711
10,197
12,670
12,67010,19710,71122,25015,78126,11415,07313,13015,016
       Short-term Debt 
395
1,272
3,341
6,530
5,913
7,732
790
723
2,436
2,4367237907,7325,9136,5303,3411,272395
       Short Long Term Debt 
395
1,272
3,341
11,053
1,501
0
0
0
0
00001,50111,0533,3411,272395
       Accounts payable 
2,631
2,107
1,899
2,470
3,970
2,076
2,944
3,441
4,450
4,4503,4412,9442,0763,9702,4701,8992,1072,631
       Other Current Liabilities 
4,681
3,021
3,070
4,081
3,068
2,014
2,870
2,642
2,581
2,5812,6422,8702,0143,0684,0813,0703,0214,681
   > Long-term Liabilities 000000000
       Long term Debt Total 
0
0
0
0
0
0
16,641
18,063
16,194
16,19418,06316,641000000
> Total Stockholder Equity
9,266
9,793
10,201
10,728
11,655
11,871
12,951
12,605
14,027
14,02712,60512,95111,87111,65510,72810,2019,7939,266
   Common Stock
12,032
12,032
12,032
12,032
12,032
12,032
12,032
12,032
12,032
12,03212,03212,03212,03212,03212,03212,03212,03212,032
   Retained Earnings 
-3,629
-3,096
-2,766
-2,171
-1,312
-1,096
-7
-382
960
960-382-7-1,096-1,312-2,171-2,766-3,096-3,629
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 
0
0
935
935
935
935
935
935
935
93593593593593593593500
   Treasury Stock000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue45,381
Cost of Revenue-31,413
Gross Profit13,96813,968
 
Operating Income (+$)
Gross Profit13,968
Operating Expense--
Operating Income2,41613,968
 
Operating Expense (+$)
Research Development-
Selling General Administrative4,265
Selling And Marketing Expenses-
Operating Expense-4,265
 
Net Interest Income (+$)
Interest Income779
Interest Expense--
Other Finance Cost-779
Net Interest Income-
 
Pretax Income (+$)
Operating Income2,416
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,5222,416
EBIT - interestExpense = 2,725
1,522
1,419
Interest Expense-
Earnings Before Interest and Taxes (EBIT)2,7251,522
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax1,522
Tax Provision-103
Net Income From Continuing Ops-1,419
Net Income1,419
Net Income Applicable To Common Shares1,419
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,115
Total Other Income/Expenses Net-0
 

Technical Analysis of Evrofarma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Evrofarma. The general trend of Evrofarma is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Evrofarma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Evrofarma SA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.75 < 1.87 < 1.94.

The bearish price targets are: 1.31 > 1.28 > 1.28.

Tweet this
Evrofarma SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Evrofarma SA. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Evrofarma SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Evrofarma SA. The current macd is -0.04889064.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Evrofarma price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Evrofarma. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Evrofarma price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Evrofarma SA Daily Moving Average Convergence/Divergence (MACD) ChartEvrofarma SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Evrofarma SA. The current adx is 23.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Evrofarma shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Evrofarma SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Evrofarma SA. The current sar is 1.6248.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Evrofarma SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Evrofarma SA. The current rsi is 34.62. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Evrofarma SA Daily Relative Strength Index (RSI) ChartEvrofarma SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Evrofarma SA. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Evrofarma price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Evrofarma SA Daily Stochastic Oscillator ChartEvrofarma SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Evrofarma SA. The current cci is -127.76593399.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Evrofarma SA Daily Commodity Channel Index (CCI) ChartEvrofarma SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Evrofarma SA. The current cmo is -47.78684256.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Evrofarma SA Daily Chande Momentum Oscillator (CMO) ChartEvrofarma SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Evrofarma SA. The current willr is -90.90909091.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Evrofarma SA Daily Williams %R ChartEvrofarma SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Evrofarma SA.

Evrofarma SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Evrofarma SA. The current atr is 0.08351969.

Evrofarma SA Daily Average True Range (ATR) ChartEvrofarma SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Evrofarma SA. The current obv is 626,399.

Evrofarma SA Daily On-Balance Volume (OBV) ChartEvrofarma SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Evrofarma SA. The current mfi is 32.33.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Evrofarma SA Daily Money Flow Index (MFI) ChartEvrofarma SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Evrofarma SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Evrofarma SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Evrofarma SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.625
Ma 20Greater thanMa 501.682
Ma 50Greater thanMa 1001.598
Ma 100Greater thanMa 2001.406
OpenGreater thanClose1.490
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Evrofarma with someone you think should read this too:
  • Are you bullish or bearish on Evrofarma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Evrofarma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Evrofarma SA

I send you an email if I find something interesting about Evrofarma SA.


Comments

How you think about this?

Leave a comment

Stay informed about Evrofarma SA.

Receive notifications about Evrofarma SA in your mailbox!